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Summary
Objective: To verify if, in the last two decades, there have been any changes in
epidemiological, clinical, diagnostic, therapeutic and prognostic aspects of patients
with brain abscess.
Method: We studied retrospectively 100 patients discharged over a 17-year period
from Ca’ Foncello Regional Hospital, Treviso, Italy with a diagnosis of brain abscess.
Results: Post-surgical abscesses were more frequent than those related to contiguous
infections and the spectrum of etiologic agents was very heterogeneous. A cerebral
neoplasm was the initial neuroradiological diagnosis in 13 patients; 72 patients
underwent a neurosurgical procedure. A comatose state at presentation was asso-
ciated with an unfavourable outcome.
Conclusion: With the exception of some epidemiological aspects, which varied from
the literature, in spite of the improvements in diagnostic procedures and treatment,
no significant changes occurred in the prognosis of patients with brain abscess.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Brain abscess is a focal suppurative process of the
brain parenchyma that can arise by extension of
contiguous infections,1—7 penetrating head injury,8,9
neurosurgical procedures,10 or hematogenous spread* Corresponding author. Tel.: +39 422 322050;
ax: +39 422 322645.
E-mail address: evatonon@tiscali.it (E. Tonon).
201-9712/$32.00 # 2005 International Society for Infectious Diseas
oi:10.1016/j.ijid.2005.04.003from distant extracranial sources.11 Microorganisms
most frequently isolated are viridans streptococci,
Staphylococcus aureus, Gram-negative bacilli, and
anaerobes.11,12 Computerized tomography (CT) and
magnetic resonance (MR) have revolutionized the
diagnosis and management of patients with brain
abscess and have permitted the assessment of
the response to therapy.13—16 Treatment is usually
combined, surgical and medical,13,17 and selected
cases can be treated only with medical therapy.18,19es. Published by Elsevier Ltd. All rights reserved.
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Table 1 Patient characteristics and presenting signs
and symptoms.
Mean age (years) 49.06  18.03
(range 6—84)
Patients transferred from
other hospital (%)
70
Patients admitted by local
Emergency Care Unit (%)
30
Duration of symptoms
before diagnosis (days)
13.21  11.73
(range 0—60)
Fever (%) 79
Headache (%) 59
Neurological focal deficits (%) 66
Seizures (%) 27
Coma (%) 21Aspiration or excision of lesions with >2.5 cm dia-
meter or causing mass effect is recommended.11
Materials and methods
Case sheets of patients discharged from Ca’
Foncello Regional Hospital (Treviso, Italy) with
a 324 code diagnosis (International Classification
of Diseases, 9th revision, Clinical Modification,
1997) from January 1985 to December 2001
were examined retrospectively. Ca’ Foncello
Regional Hospital has a neurosurgical unit for both
adults and pediatric cases, which is the reference
centre for area of almost one million of inhabi-
tants.
Brain abscess was defined as a localized lesion,
visible on CT or MR scan, located in the cerebrum,
cerebellum or midbrain, which met at least one of
the following criteria: a positive culture of intracerebral material;
 at least two positive blood cultures;
 brain abscess at histology;
 neuroradiological findings suggesting brain
abscess plus radiological and clinical response
to antimicrobial therapy.
The material obtained from cerebral lesions was
examined by standard microbiological methods and
histology.
Since 1999 a protocol of specimen collection has
been agreed between the neurosurgical unit and
microbiology laboratory: 1 ml of pus, collected anaerobically is placed in an
anaerobic blood culture bottle; 1 ml of pus is placed in an aerobic blood culture
bottle; the remaining specimen is placed in a sterile test-
tube and immediately sent to the microbiology
laboratory and examined by direct microscopic
observation and cultured for aerobic and anaero-
bic bacteria, mycetes and mycobacteria. Outside
normal hours the specimens are kept at room
temperature and sent to the laboratory as soon
as possible.
Since 1990, serology for HIV (ELISA) has been
performed in all patients with encephalic lesions
and HIV seropositive subjects were excluded from
our study. Statistical analysis was carried out by
comparison of groups with quantitative continuous
variables using the Student’s t-test, while the x2 test
was used for comparison of groups with qualitative
variables on nominal scale. A p value of 0.05 wasconsidered significant. Data are given as mean
 standard deviation.Results
Patients
From January 1985 to December 2001 one hundred
cases of brain abscess were diagnosed (Table 1). The
onset of symptoms before diagnosis varied from a
few hours to 60 days, with a mean of 13.21 days
(11.73). A predisposing factor was recognized in 68
patients (Table 2).
Neuroradiological findings
In only one patient did CTand MR show cerebritis. In
all the other cases one or more capsulated lesions
were present (Table 3). In 87 patients neuroradio-
logical imaging was suggestive of brain abscess,
while in 13 a cerebral neoplasm was initially sus-
pected and only by surgical approach was the cor-
rect diagnosis made.
Microbiological findings
Etiological diagnosis was possible for 60 patients: in
41 cases by brain material culture, in 14 by blood
culture and in five by other methods (Table 2). Forty-
three microorganisms were cultured from cerebral
pus (two polymicrobial abscesses): a positive culture
was obtained in 68.3% of the patients without pre-
vious antibiotic therapy and only in 35.5% of the
patients already receiving antimicrobial therapy.
The probability of isolating the causal agent was
significantly higher in the group of patients not trea-
ted with antibiotics (p = 0.011). Cerebrospinal fluid
culturewaspositive infiveoutof14patients: in three
cases it confirmed the microbiological diagnosis
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Table 2 Etiological agent in relation to the pathogenesis of the brain abscess.
Pathogenesis (n) Positive
cerebral pus
culture (n)
Microorganisms
isolated from brain
abscess material (n)
Microorganisms
isolated from
blood cultures (n)
Cultures of other
specimens or
histology (n, site)
Iatrogenic (28) 9/20
(2 poly-
microbial)
S. aureus (5) S. aureus (3) P. aeruginosa (1, CSF)
Coagulase-negative
staphylococcus (1)
C. diversus (1)
R. equi (1)
E. faecalis (1)
Alcaligenes sp (1)
P. rettgeri (1)
Post-traumatic (2) 1/1 Gemella morbillorum (1) — S. pneumoniae (1, CSF)
Otogenic (12) 6/10 P. mirabilis (3) —
P. vulgaris (1)
Micrococcus varians (1)
Peptostreptococcus
sp (1)
Dental (7) 2/6 a-hemolytic
streptococcus (1)
—
S. sanguis (1)
Orbital cellulitis (1) 0/0 — —
Sinogenic (1) 1/1 Peptostreptococcus
sp (1)
—
Hematogenous (17) 3/5 S. oralis (1) S. aureus (7) K. pneumoniae
(1, bronchial aspirate)aS. constellatus (1) a-hemolytic
streptococcus (1)
L. monocytogenes (1) L. monocytogenes (1) A. fumigatus
(1, bronchial aspirate)aP. aeruginosa (1)
Cryptogenic (32) 19/29 S. constellatus (3) S. intermedius (1) Blastomyces
(1, histology)aS. intermedius (3)
G. morbillorum (3)
S. mutans (1)
S. salivarius (1)
E. faecalis (1)
S. aureus (1)
H. influenzae (1)
H. parainfluenzae (1)
Micrococcus sp (1)
F. nucleatum (1)
Lactobacillus
fermentans (1)
B. oralis (1)
CSF = cerebrospinal fluid.
a Patient with lung and brain lesions.already obtained with blood cultures and culture
of cerebral pus; in two cases microorganisms with a
probable causal role were isolated (Table 2).
Treatment
Twenty-eight patients were treated only by medical
therapy, while 72 patients underwent one (65patients) or more (7 patients) surgical approaches.
Thirty-six patients were treated with stereotaxis,
which was repeated in two cases for persistence of
the lesion. ‘Freehand’ closed drainage and open
surgical drainage were performed in 20 and eight
cases, respectively. Eight patients were treated
with the excision of the lesion (one patient under-
went a second excision). In three cases the endo-
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Table 3 Neuroradiological findings.
Number of
patients n (%)
Location of the
lesions (n; %)
Mean dimension of the lesions
(available for 42 patients) (mm)
Single brain abscess 75 (75%) Frontal (23; 30.7%) 33.93  13.68 (range 10—60)
Parietal (20; 26.7%)
Temporal (12; 16%)
Temporoparietal (9; 12%)
Occipital (3; 4%)
Frontoparietal (3; 4%)
Cerebellar (3; 4%)
Thalamic (2; 2.6%)
Multiple brain abscesses 25 (25%) (Not applicable)scopic approach was preferred. In one patient an
infected ventriculo-peritoneal shunt, responsible
for the brain abscess, was removed.
Data related to the medical therapy were avail-
able for 99 patients. All patients were treated with
intravenous antimicrobial agents and in 85 cases
with an antimicrobial combination. The most fre-
quently used regimens were a b-lactam (penicillin
G, ampicillin, cefotaxime, ceftriaxone) plus chlor-
amphenicol or metronidazole (51 patients). The
mean length of intravenous therapy (data for 80
patients) was 45.84 days (15.23), range 14—100
days. Parenteral antimicrobial therapy was
switched to an oral regimen in 34 patients (mean
24.14 days). Corticosteroids were administered in
67 patients and intravenous mannitol in 48 cases,
alone or associated with cortisteroids; 83 patients
received anticonvulsants.
Outcome
Ninety-six patients were evaluable at the end of the
therapy: 80 (83.3%) were cured, eight (8.3%) died
(five of them were in coma at admission), seven had
a relapse of the abscess, and one patient had a
persistent brain abscess with a chronic cutaneous
fistula, despite two excisions. Death was due to
brain abscess in seven patients; one patient with
bacterial endocarditis died of cardiac decompensa-
tion. Follow-up was available for 58 patients (mean
duration 11.48 months  7.73). Sequelae were pre-
sent in 21 cases (36.2%): focal deficit in 14 patients
(24.1%), epilepsy in three cases (5.2%), hydrocepha-
lus in three cases (5.2%), and mental disorder in one
case (1.7%). There was no significant difference
among patients who died or had sequelae and the
patients without sequelae, as regard sex, age,
length of symptoms before diagnosis, number and
dimension of the abscesses, and medical and surgi-
cal therapy; only a comatose state at admission wasrelated to an unfavourable outcome ( p = 0.007)
(Table 4).Discussion
Since brain abscess is an uncommon disease, it is
difficult to perform a prospective trial to compare
the efficacy of different medical and surgical treat-
ments.20 Moreover, few retrospective studies on a
large number of cases have been published, espe-
cially in the last ten years.21—25 In our review,
including 100 patients, we found a lower incidence
of abscesses secondary to extension of contiguous
infections than other studies (21% versus about
50%), in particular those associated with paranasal
sinuses and ear infections.2,26—28 We think that this
may be due to the common antibiotic and surgical
treatment of patients with chronic otitis and sinu-
sitis. By contrast, post-surgical cases were particu-
larly highly represented (28%). These data can be
related to the increasing number of patients that
undergo neurosurgical procedures and to the fact
that our Neurosurgery Division is the reference
centre of Treviso province (Italy).
A microbiological diagnosis was possible by the
isolation of the microorganism from intracerebral
material in 41 patients and from blood cultures in 14
cases. Lumbar puncture showed a low sensitivity in
identification of the etiological agent, therefore,
considering the risk of cerebral or cerebellar hernia-
tion, we agree that lumbar puncture must be
contraindicated in this clinical condition.13,27 Strep-
tococcal etiology was less common than reported in
the literature and this is probably related to the low
incidence of abscesses secondary to paranasal
sinuses and ear infections.29,30 The low prevalence
of anaerobes and polymicrobic brain abscesses,
compared with the literature, could be due to
methods of specimen collection and transport that
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Table 4 Prognosis according to sex, age, duration of symptoms before diagnosis, presenting symptoms (fever),
number and dimension of brain abscesses, medical and surgical treatment.
Variable Death or
sequelae (n = 29)
Cure without
sequelae (n = 37)
Total
(n = 66)
p
Value
Male 17 24 41 0.792
Female 12 13 25
Age (years) 51.55 (19.15) 44.41 (17.83) 47.55 (18.62) 0.123
Duration of symptoms (days) 14.28 (11.90) 11.38 (9.63) 12.65 (10.70) 0.278
Fever 22 28 50 0.786
No fever 7 9 16
Coma 10 2 12 0.007
No coma 19 35 54
Solitary abscess 22 31 53 0.623
Multiple abscesses 7 6 13
Surgery 21 25 46 0.877
No surgery 8 12 20
Corticosteroids 20 23 43 0.752
No corticosteroids 9 14 23
Diameter of the abscess (mm) 33.86 (11.44)
(n = 14)
29.63 (13.34)
(n = 16)
31.60 (12.46)
(n = 30)
0.363
Duration of intravenous
antimicrobial therapy (days)
43.75 (12.9)
(n = 21)
46.56 (16.55)
(n = 37)
45.55 (15.2)
(n = 58)
0.505did not ensure an adequate anaerobiosis, especially
before 1999.12,31 Since 1999 a collection protocol
has been agreed between the neurosurgical unit and
microbiology laboratory, but the low number of
patients did not permit us to verify the efficacy of
the new method of specimen collection. The spec-
trum of the microorganisms isolated from post-sur-
gical brain abscesses is different from that from
spontaneous and community-acquired abscesses
and reflects the etiology of post-surgical nosocomial
infections: staphylococci are the most common
agents, while other microorganisms are responsible
for only sporadic cases. A positive culture was sig-
nificantly more frequent in patients not previously
treated with antibiotics and so when the brain
abscess requires a surgical approach, it is better
to perform it as soon as possible and then start
antibiotic therapy.
Neuroradiological imaging does not have absolute
specificity:7,13—16 in 13 patients CT or MR scan sug-
gested a cerebral neoplasm; only a surgical
approach permitted the correct diagnosis. CT and
MR scans showed cerebritis in only one patient,
while in all the other cases there were one or more
capsulated lesions. This suggests that the diagnosis
of cerebritis is difficult because symptoms and signs
are mild and the patient does not request medical
assistance.The majority of patients with brain abscess
underwent a neurosurgical procedure with both
diagnostic and therapeutic aims (72%). Stereotactic
drainage was the procedure of choice (36 patients),
especially in more recent years, followed by ‘free-
hand’ closed drainage; open surgical drainage and
lesion excision by craniotomy have become obsolete
procedures.13,32,33 In recent years the utility of the
endoscopic approach, performed in three patients,
has been valued.34,35 Medical therapy alone was
used in the treatment of 28% of the patients, usually
subjects with multiple, inaccessible and small
lesions, often secondary to hematogenous spread.
These are patients with frequently positive blood
cultures (especially Staphylococcus aureus endocar-
ditis), so the antimicrobial therapy can be guided by
antibiotic sensitivity.
Combination of a b-lactam antibiotic with chlor-
amphenicol (until 1995) or metronidazole was the
most frequently used antimicrobial therapy. All the
patients were treated with intravenous antibiotics;
the mean duration of parenteral antimicrobial ther-
apy was about six weeks, in accordance with the
most common recommendations.13 One third of
patients were switched to an oral regimen, but
it is not possible from our data to define the utility
of oral therapy in the treatment of brain
abscesses.13 A recent local protocol of initial empiri-
108 E. Tonon et al.cal antimicrobial therapy (January 2000) includes
the combination of vancomycin and meropenem in
post-surgical cases and the combination of a third-
generation cephalosporin and metronidazole in
spontaneous cases, with the addition of an anti-
staphylococcal drug (oxacillin or vancomycin) if
endocarditis is suspected. Most patients were trea-
ted with corticosteroids, without influence on the
prognosis, as reported in other studies;27,31,36 so
corticosteroids should be reserved for patients
with severe cerebral edema or risk of cerebral
herniation.13
The mortality rate was comparable to published
data.4,21,25,27 Only the presence of a comatose state
at admission was related to an unfavourable out-
come, both for death and sequelae.31 It was note-
worthy that age, duration of symptoms before
diagnosis, identification of the etiological microor-
ganism, number and dimensions of the abscesses,
and medical and surgical therapy did not influence
the prognosis.
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